Get the Stockscreener App
78.84
1.46%
-1.17
Disc Medicine Inc stock is traded at $78.84, with a volume of 262.50K.
It is down -1.46% in the last 24 hours and up +5.11% over the past month.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
See More
Previous Close:
$80.01
Open:
$79.53
24h Volume:
262.50K
Relative Volume:
0.49
Market Cap:
$3.03B
Revenue:
-
Net Income/Loss:
$-241.60M
P/E Ratio:
-11.92
EPS:
-6.6167
Net Cash Flow:
$-201.34M
1W Performance:
+1.81%
1M Performance:
+5.11%
6M Performance:
+40.91%
1Y Performance:
+29.84%
1-Day Range:
$77.99
$80.65
1-Week Range:
$75.79
$83.12
52-Week Range:
$40.00
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Name
Disc Medicine Inc
Sector
Industry
Phone
(617) 674-9274
Address
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
78.84 | 3.09B | 0 | -241.60M | -201.34M | -6.6167 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Resumed | Stifel | Buy |
| Jul-21-25 | Initiated | Truist | Buy |
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Jun-11-25 | Resumed | Raymond James | Strong Buy |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-04-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-23-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-01-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-19-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-09-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jun-07-23 | Initiated | H.C. Wainwright | Buy |
| May-17-23 | Initiated | Raymond James | Outperform |
| Apr-28-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-21-23 | Initiated | Stifel | Buy |
| Apr-20-23 | Initiated | Morgan Stanley | Overweight |
| Mar-23-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-28-23 | Initiated | SVB Securities | Outperform |
View All
Disc Medicine Inc Stock (IRON) Latest News
Insider Selling: Disc Medicine (NASDAQ:IRON) COO Sells 804 Shares - MarketBeat
Disc Medicine COO Jonathan Yu sells $66,444 in shares By Investing.com - Investing.com UK
Disc Medicine COO Jonathan Yu sells $66,444 in shares - Investing.com
Disc Medicine (NASDAQ: IRON) COO trades 804 shares via 10b5-1 plan - Stock Titan
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), ... - Caledonian Record
Disc Medicine Investor News: If You Have Suffered Losses in - GlobeNewswire
Sei Investments Co. Takes Position in Disc Medicine, Inc. $IRON - MarketBeat
FMR LLC Trims Disc Medicine Inc (IRON) Stake: A Strategic Reduction Amid Biotech Volatility - GuruFocus
Renaissance Technologies LLC Sells 31,000 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Price-Driven Insight from (IRON) for Rule-Based Strategy - Stock Traders Daily
The Manufacturers Life Insurance Company Decreases Stock Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. $IRON Shares Sold by Assenagon Asset Management S.A. - MarketBeat
HC Wainwright Decreases Earnings Estimates for Disc Medicine - MarketBeat
Disc Medicine Inc (IRON) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Rahul Khara, Disc Medicine CLO, sells $400,000 in shares By Investing.com - Investing.com Australia
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns - Stocktwits
Rahul Khara, Disc Medicine CLO, sells $400,000 in shares - Investing.com
Disc Medicine (NASDAQ:IRON) Insider Rahul Khara Sells 5,000 Shares - MarketBeat
Disc Medicine Chief Legal Officer Rahul Khara disposes of 5,000 common shares for $400,000 - Bitget
Disc Medicine Insider Sold Shares Worth $400,000, According to a Recent SEC Filing - Moomoo
Disc Medicine (NASDAQ: IRON) CLO sells 5,000 shares after option exercise - Stock Titan
FY2029 EPS Estimates for Disc Medicine Lowered by Analyst - MarketBeat
Disc Medicine (IRON) 10K Form and Latest SEC Filings 2026 - MarketBeat
IRON (IRON) filer plans 5,000-share stock sale after option exercise - Stock Titan
Disc Medicine (IRON): FMR LLC, Abigail Johnson report 12.8% ownership of common stock - Stock Titan
HC Wainwright Forecasts Strong Price Appreciation for Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
IRON Maintained by HC Wainwright & Co. -- Price Target Raised to $120 - GuruFocus
H.C. Wainwright Maintains Disc Medicine(IRON.US) With Buy Rating, Announces Target Price $120 - Moomoo
Dimensional Fund Advisors LP Raises Holdings in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. Revenue Breakdown – NASDAQ:IRON - TradingView
Disc Medicine, Inc. (IRON) Stock Analysis: Exploring a 32% Potential Upside with Strong Buy Ratings - directorstalkinterviews.com
Lazard Asset Management LLC Lowers Stock Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - fairfaxtimes.com
Bank of New York Mellon Corp Raises Holdings in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine (NASDAQ:IRON) Upgraded at Wall Street Zen - MarketBeat
How Investors Are Reacting To Disc Medicine (IRON) Balancing Larger Losses With APOLLO Phase 3 FDA Alignment - simplywall.st
Truist Financial Maintains Disc Medicine(IRON.US) With Buy Rating, Announces Target Price $83 - Moomoo
SummitTX Capital L.P. Buys Shares of 13,820 Disc Medicine, Inc. $IRON - MarketBeat
IRON SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
(IRON) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Rosen Law Firm investigates Disc Medicine over potential securities claims - scanx.trade
Disc Medicine on Track to Report APOLLO Topline Results in 4Q >IRON - Moomoo
Disc Medicine reports Q2 net loss of $59.5 million - quiverquant.com
Disc Medicine Q2 Results: EPS beats estimates, losses narrow YoY - scanx.trade
Disc Medicine Inc. Q1 2026 Earnings: EPS Surprise of 5.57% Driven by Tight Expense ControlEstimate Dispersion - dars.gov.et
Disc Medicine, Inc. (IRON) Stock Analysis: Unveiling a 36% Upside Potential in Biotech Innovation - DirectorsTalk Interviews
Octagon Capital Advisors LP Makes New Investment in Disc Medicine, Inc. $IRON - MarketBeat
TradingKey - TradingKey
Disc Medicine Inc (IRON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Disc Medicine Inc (IRON) Institutional Confidence - TradingKey
Disc Medicine Inc Stock (IRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):